Jeffrey Schmidt

MedTech Advisor

Innovation · Digital · AI

Bio

I have spent more than two decades in MedTech, leading R&D, innovation, digital, AI, software, and services businesses at GE HealthCare, BD, Carl Zeiss Meditec, and Welch Allyn. Before that, I worked in enterprise technology and aerospace at Peak Technologies, Sun Microsystems, McDonnell Douglas, and the U.S. Air Force.Much of my career has been spent helping businesses create or regain growth when existing innovation strategies, portfolios, and operating models were no longer delivering. My work has included rebuilding portfolios and teams, accelerating development, creating digital businesses, integrating acquisitions, and redirecting investment toward higher-return opportunities.The results have been consistent: development cycles cut by more than half, growth accelerated to multiples of market rates, launch predictability improved, R&D intensity reduced while output expanded, and digital businesses created that generated both new revenue and pull-through for core portfolios.Today I advise leadership teams, investors, and governments on turning technology and innovation investment into growth.


Selected leadership experience

GE HealthCare · 2023–2025

Chief Innovation Officer, Advanced Visualization Solutions ($5B+ business)
Chief Technology Officer, Image Guided Therapies ($2B+ business)

BD · 2021–2023

VP R&D, Vascular Access Devices ($2B+ business)
VP Front-End Innovation, Medication Delivery Solutions ($4.5B business)

Carl Zeiss Meditec · 2014–2021

VP R&D, Ophthalmic Diagnostics ($500M+ business)
Head of AI, company-wide

Welch Allyn · 2003–2014

VP International R&D
GM, Global Services ($30M business in a $700M+ company)

Earlier

Technology, digital, and operational leadership at Peak Technologies, Sun Microsystems, McDonnell Douglas, and the U.S. Air Force


Advisory and public sector

Singapore MedTech Ecosystem · 2026–2028

Member of the A*STAR MedTech International Advisory Panel, advising Singapore’s lead public sector R&D agency on aligning MedTech development with national priorities and global market needs

Singapore Biomedical Ecosystem · 2010–2014

Chair, Industry Chapter Advisory Board, Biomedical Engineering Society
Member, Bioengineering Departmental Consultative Committee, National University of Singapore
Selection committee member, President's Technology Award
Guest lecturer, Singapore-Stanford Biodesign


Patents and technical contributions

US 12,303,197 B2 (2025) · US 10,918,278 B2 (2021) · US 10,028,658 B2 (2018)Four systems-architecting heuristics cited in The Art of Systems Architecting (Maier & Rechtin)



Summit Park Advisory LLC · Park City, Utah · [email protected]